Raines Monica reported option exercise involving 2,062 shares of Addus HomeCare Corp at $34.05 for $70.2k on Nov 6, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
EVP, CCO and Quality Officer
EVP, CCO and Quality Officer
Filed Nov 10, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$70,211.10Shares × reported price
Shares traded
2,062Common Stock
Price per share
$34.05Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
15,639Direct
Trade date
Nov 6, 2026Option exercise
Filed
Nov 10, 2026, 4:31 PM ET4-day reporting delay
Accession
0001437749-26-036192Code M · Transaction 397113
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 6, 2026Sell2,062$124.74−$257,213.88Trade 397114
Nov 6, 2026Option exercise2,062$0.00$0Trade 397115
3 transaction rows in this filing. Joint filers share the same rows.

ADUS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ADUS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −7.3%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.59 to $124.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2: All options are fully vested.